Alaina V Burns, MD
Psychiatry · Los Angeles
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 14 years
- State University of New York Downstate Medical Center, 2012
Offices
1 location · UC Regents · 148 clinicians in this group
Hospitals listed: Ronald Reagan UCLA Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Burns’s office at (310) 825-9989 to ask if they take your plan before you enroll.
California Medical Board record
Licence A128507 · Current
Licensed to practise in California · since 2014 · expires 2027-05-31 · State University of New York, Downstate Medical Center College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Psychiatry and Neurology - Psychiatry
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Ronald Reagan UCLA Medical CenterLos Angeles, CAAcute Care Hospital · Government - State · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of Jonsson Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 3 of 5 · 79% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 6.27 (4.69 to 7.85) · 3,570 cases, Jul 2022 – Jun 2024Better than the national rate — Postoperative respiratory failure rate: 5.17 (1.78 to 8.56) · 1,778 cases, Jul 2022 – Jun 2024Better than the national rate — Pressure ulcer rate: 0.21 (0 to 0.62) · 8,165 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.59, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.611, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.503, Oct 2024 – Sep 2025
See every measure and the patient survey for Ronald Reagan UCLA Medical Center
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 6.27 (4.69 to 7.85) · 3,570 cases | Worse | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 5.17 (1.78 to 8.56) · 1,778 cases | Better | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.21 (0 to 0.62) · 8,165 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.59 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.611 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.503 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.67 (0 to 1.44) · 2,883 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.9 (0.7 to 1.09) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 171.14 (139.88 to 202.41) · 282 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.1 · 122 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.2 · 49 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.5 · 107 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.9 · 350 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.1 · 436 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.8 · 242 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.4 · 3,004 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 9,102 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.09 to 0.44) · 10,460 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.67 (0.57 to 2.77) · 1,972 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.27 to 3.44) · 3,000 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.93 (3.76 to 8.09) · 2,101 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.65 (1.31 to 3.98) · 1,032 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.56 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.626 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.8 · 138 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 357 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -7.1 · 122 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -12.9 · 385 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 13.6 · 427 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 404 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (3.7 to 6.5) · 609 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.3 (10.1 to 15) · 609 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 10.8 · 119 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.8 · 49 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 10.8 (8.5 to 13.7) · 2,701 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,463 cases | No different | Jan 2024 – Dec 2024 |
What patients said (814 patients answered, 18% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$23,068
Medicare paid this office $23,068 for 54 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 30 | $12,069 | $70 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $2,863 | $136 |
| Psychiatric diagnostic evaluation with medical services | 14 | $2,113 | $151 |
Who their Medicare patients are
54 Original Medicare patients in 2024. Average age 59 · Under 65 50% · Women 61% · Also on Medicaid 61% · Health risk score 1.79. Above the middle of the specialty; the typical psychiatry clinician is at 1.35.
Conditions among them: High blood pressure 70% · Depression 67% · Diabetes 46% · Coronary heart disease 37% · Chronic kidney disease 33% · Heart failure 31% · Dementia 26% · Atrial fibrillation 22%.
The office billed $161,326, Medicare allowed $29,764 and paid $23,068; for 270 services of 9 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 54 | 270 | 59 | 1.79 | $161,326 | $23,068 |
| 2023 | 60 | 214 | 60 | 2.92 | $128,328 | $18,391 |
| 2022 | 55 | 218 | 64 | 2.42 | $122,739 | $17,090 |
| 2021 | 55 | 403 | 57 | 1.87 | $226,692 | $31,155 |
| 2020 | 85 | 356 | 59 | 2.05 | $146,400 | $27,160 |
| 2019 | 105 | 460 | 57 | 1.74 | $175,854 | $32,916 |
| 2018 | 81 | 376 | 52 | 1.46 | $141,260 | $26,767 |
| 2017 | 93 | 244 | 54 | 1.81 | $84,012 | $15,719 |
| 2016 | 53 | 82 | 53 | 1.55 | $29,663 | $6,931 |
| 2015 | 16 | 30 | 69 | 2.21 | $3,433 | $2,232 |
| 2014 | 15 | 43 | 68 | 2.06 | $5,508 | $2,267 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 31 | $8,148 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,231 | $139 |
| Psychiatric diagnostic evaluation with medical services | 14 | $2,038 | $146 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,224 | $102 |
2022: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $7,986 | $60 |
| Psychiatric diagnostic evaluation with medical services | 15 | $2,160 | $144 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,138 | $153 |
2021: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 40 | $18,150 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $5,632 | $176 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 22 | $3,937 | $89 |
2020: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 40 | $10,855 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $7,467 | $86 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $2,512 | $140 |
| Psychiatric diagnostic evaluation with medical services | 14 | $1,718 | $123 |
| Hospital discharge day management, more than 30 minutes | 14 | $1,256 | $90 |
| Short return visit (20+ min) | 12 | $511 | $36 |
2019: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 66 | $19,847 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $4,790 | $171 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 19 | $3,024 | $89 |
| Short return visit (20+ min) | 15 | $1,720 | $59 |
| Return visit (30+ min) | 15 | $1,457 | $73 |
2018: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 50 | $17,402 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 21 | $3,601 | $164 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $2,395 | $89 |
| Short return visit (20+ min) | 17 | $1,337 | $56 |
2017: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 51 | $8,657 | $57 |
| Short return visit (20+ min) | 32 | $2,840 | $56 |
| Psychiatric diagnostic evaluation with medical services | 11 | $1,311 | $119 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $976 | $89 |
2016: 2 services
| Short return visit (20+ min) | 29 | $2,528 | $63 |
| Psychiatric diagnostic evaluation with medical services | 16 | $1,828 | $114 |
2015: 1 service
| Return visit (30+ min) | 14 | $2,003 | $77 |
2014: 1 service
| Brief office visit for the sole purpose of monitoring or changing drug prescriptions used in the treatment of mental psychoneurotic and personality disorders | 14 | $1,986 | $48 |
Drugs they prescribed that Part D paid
$32,982
Pharmacies billed $32,982 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 231) in 2024. At or below the middle of the specialty; the typical psychiatry clinician is at 0%.
213 generic and 18 brand-name prescriptions · $32,982 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Lurasidone | 15 | $6,921 | $461 |
| Venlafaxine Hcl Er | 14 | $508 | $36 |
| Clozapine | 15 | $453 | $30 |
| Bupropion Xl | 12 | $293 | $24 |
| Gabapentin | 15 | $244 | $16 |
See all 7 drugs
| Lurasidone | 15 | $6,921 | $461 |
| Venlafaxine Hcl Er | 14 | $508 | $36 |
| Clozapine | 15 | $453 | $30 |
| Bupropion Xl | 12 | $293 | $24 |
| Gabapentin | 15 | $244 | $16 |
| Quetiapine | 15 | $160 | $11 |
| Clonazepam | 11 | $106 | $10 |
Year by year
| 2024 | 231 | 27 | 0% (0) | 8% | $32,982 |
| 2023 | 199 | 21 | 0% (0) | 8% | $36,434 |
| 2022 | 86 | 15 | 0% (0) | 24% | $44,123 |
| 2021 | 128 | 20 | 0% (0) | 20% | $47,862 |
| 2020 | 78 | 20 | None | 24% | $31,015 |
| 2019 | 250 | 45 | None | 8% | $34,799 |
| 2018 | 371 | 56 | 0% (0) | 11% | $65,602 |
| 2017 | 588 | 58 | 0% (0) | 11% | $64,501 |
| 2016 | 358 | 63 | 0% (0) | 7% | $17,968 |
| 2015 | 1,008 | 82 | 0% (0) | 9% | $75,851 |
| 2014 | 491 | 64 | None | 13% | $55,190 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Gabapentin | 13 | $707 | $54 |
| Bupropion Xl | 12 | $601 | $50 |
| Venlafaxine Hcl Er | 18 | $596 | $33 |
| Clozapine | 21 | $452 | $22 |
2022: 2 drugs
| Latuda | 12 | $27,450 | $2,288 |
| Venlafaxine Hcl Er | 13 | $319 | $25 |
2021: 2 drugs
| Latuda | 15 | $38,227 | $2,548 |
| Olanzapine | 11 | $129 | $12 |
2020: 1 drug
| Latuda | 14 | $26,145 | $1,868 |
2019: 6 drugs
| Latuda | 12 | $21,567 | $1,797 |
| Clozapine | 27 | $2,160 | $80 |
| Quetiapine | 18 | $648 | $36 |
| Gabapentin | 23 | $514 | $22 |
| Hydroxyzine | 11 | $145 | $13 |
| Risperidone | 16 | $74 | $5 |
2018: 11 drugs
| Latuda | 20 | $32,922 | $1,646 |
| Aripiprazole | 22 | $5,200 | $236 |
| Duloxetine | 27 | $1,952 | $72 |
| Clozapine | 40 | $1,634 | $41 |
| Bupropion Xl | 28 | $624 | $22 |
| Quetiapine | 13 | $544 | $42 |
| Gabapentin | 22 | $429 | $20 |
| Lithium Carbonate Er | 15 | $371 | $25 |
| Sertraline | 14 | $118 | $8 |
| Trazodone | 22 | $115 | $5 |
| Metformin Hcl Er | 12 | $86 | $7 |
2017: 18 drugs
| Latuda | 16 | $28,222 | $1,764 |
| Aripiprazole | 29 | $6,451 | $222 |
| Dextroamphetamine-Amphet Er | 13 | $1,852 | $142 |
| Clozapine | 32 | $1,381 | $43 |
| Duloxetine | 38 | $1,265 | $33 |
| Bupropion Xl | 42 | $1,259 | $30 |
| Quetiapine | 36 | $486 | $14 |
| Gabapentin | 32 | $464 | $14 |
| Risperidone | 24 | $347 | $14 |
| Venlafaxine Hcl Er | 32 | $337 | $11 |
| Trazodone | 36 | $324 | $9 |
| Lithium Carbonate Er | 11 | $310 | $28 |
| Fluoxetine | 29 | $252 | $9 |
| Escitalopram | 16 | $216 | $13 |
| Olanzapine | 18 | $198 | $11 |
| Lithium Carbonate | 22 | $149 | $7 |
| Citalopram Hbr | 19 | $133 | $7 |
| Sertraline | 12 | $94 | $8 |
2016: 10 drugs
| Suboxone | 12 | $2,673 | $223 |
| Bupropion Xl | 46 | $1,194 | $26 |
| Gabapentin | 30 | $616 | $21 |
| Escitalopram | 26 | $605 | $23 |
| Quetiapine | 30 | $574 | $19 |
| Trazodone | 26 | $331 | $13 |
| Fluoxetine | 16 | $271 | $17 |
| Lamotrigine | 14 | $119 | $9 |
| Citalopram Hbr | 15 | $99 | $7 |
| Sertraline | 12 | $59 | $5 |
2015: 25 drugs
| Abilify | 26 | $27,781 | $1,069 |
| Duloxetine | 37 | $5,728 | $155 |
| Clozapine | 118 | $5,511 | $47 |
| Ziprasidone | 24 | $4,692 | $195 |
| Quetiapine | 106 | $2,203 | $21 |
| Bupropion Xl | 40 | $1,122 | $28 |
| Olanzapine | 41 | $980 | $24 |
| Venlafaxine Hcl Er | 32 | $388 | $12 |
| Risperidone | 25 | $360 | $14 |
| Gabapentin | 24 | $360 | $15 |
| Sertraline | 43 | $357 | $8 |
| Divalproex | 14 | $356 | $25 |
| Trazodone | 54 | $337 | $6 |
| Fluoxetine | 38 | $300 | $8 |
| Haloperidol | 20 | $296 | $15 |
| Lorazepam | 44 | $208 | $5 |
| Benztropine Mesylate | 17 | $206 | $12 |
| Escitalopram | 19 | $203 | $11 |
| Lamotrigine | 27 | $195 | $7 |
| Citalopram Hbr | 45 | $157 | $3 |
| Clonazepam | 34 | $118 | $3 |
| Lithium Carbonate | 16 | $91 | $6 |
| Zolpidem | 14 | $85 | $6 |
| Paroxetine | 13 | $71 | $5 |
| Diazepam | 12 | $43 | $4 |
2014: 12 drugs
| Abilify | 15 | $14,349 | $957 |
| Clozapine | 50 | $4,360 | $87 |
| Duloxetine | 15 | $2,301 | $153 |
| Quetiapine | 50 | $2,248 | $45 |
| Olanzapine | 23 | $1,486 | $65 |
| Mirtazapine | 12 | $188 | $16 |
| Gabapentin | 13 | $142 | $11 |
| Citalopram Hbr | 30 | $140 | $5 |
| Lamotrigine | 13 | $113 | $9 |
| Trazodone | 24 | $107 | $4 |
| Clonazepam | 21 | $85 | $4 |
| Lorazepam | 14 | $74 | $5 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 91.7 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1962768200
- Licence
- CA A128507California A128507: Current · expires 2027-05-31
- Trained
- State University of New York Downstate Medical Center, 2012 · 14 years ago
- Group
- UC Regents
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Psychiatry (2084P0800X)
- Mailing address
- 5767 W Century Blvd Ste 400, Los Angeles, CA, 90045
- NPI first listed
- 2012-04-11
- NPI last updated
- 2024-07-16
- NPI record certified
- 2024-07-16
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 760 Westwood Plaza, Los Angeles, CA, 90024